Vertiflex’s Superion Interspinous Spacer Gets FDA Panel Date

FDA’s Orthopaedic and Rehabilitation Devices Panel will meet in December to consider Vertiflex’s submission to support approval of the Superion interspinous spacer to treat moderate lumbar spinal stenosis.

More from Archive

More from Medtech Insight